Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered-Dose Inhaler

Clinical and Translational Science
T R MacGregorC C Wood

Abstract

The propellant-free Combivent Respimat Soft Mist Inhaler (CVT-R) was developed to replace the chlorofluorocarbon-propelled Combivent metered-dose inhaler (CVT-MDI). This steady-state pharmacokinetic (PK) substudy evaluated drug lung-delivery efficiency, using data from two phase III safety and efficacy trials. PK parameters were obtained from well-controlled population PK analyses. Area under the plasma concentration-time curve (AUC), maximum observed plasma concentration (C(max)), and minimum observed plasma concentration (C(min)) showed systemic exposure to ipratropium bromide and albuterol delivered via the CVT-R was proportional to ex-mouthpiece delivered dose. Although the labeled dose of ipratropium bromide in the CVT-R was half that in the CVT-MDI, the systemic exposure was comparable. No PK interaction for the ipratropium bromide and albuterol Respimat drug components was demonstrated. Ipratropium bromide alone resulted in similar exposure to the combination of ipratropium bromide and albuterol. These results show that CVT-R delivers drug more efficiently to the lung than CVT-MDI.

References

Jan 1, 1989·European Journal of Clinical Pharmacology·K EnsingP J Cornelissen
Jan 6, 2000·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·B Zierenberg
May 22, 2002·Therapeutic Drug Monitoring·Yohei OtsujiKoichi Otani
Dec 7, 2002·Biopharmaceutics & Drug Disposition·A MirfazaelianS Dadashzadeh
Feb 5, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·UNKNOWN Asia Pacific COPD Roundtable Group
Feb 24, 2005·Treatments in Respiratory Medicine·Wolfgang SchürmannMahmud Qidan
Sep 27, 2005·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Rajiv Dhand
Sep 27, 2005·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Dieter HochrainerHerbert Wachtel
Feb 23, 2010·Respiratory Medicine·R ZuwallackUNKNOWN Combivent Respimat Inhaler Study Group
Jul 14, 2010·Respiratory Medicine·E D BatemanN S Zhong
Aug 18, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Eric BatemanRick Hodder
May 10, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Gary T FergusonLeonard J Dunn

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00400153

Software Mentioned

WinNonlin
CVT
R
Combivent Respimat

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.